Rivia Raises €13M for Agentic AI in Trials
💡€13M for agentic AI to automate clinical trials—key for healthcare AI builders
⚡ 30-Second TL;DR
What Changed
Rivia raised €13M in new funding round
Why It Matters
This funding signals rising investor interest in agentic AI for healthcare, potentially accelerating drug development by automating trial ops and reducing inefficiencies for AI applications in medtech.
What To Do Next
Prototype agentic AI agents using frameworks like AutoGen for clinical trial data workflows.
🧠 Deep Insight
Web-grounded analysis with 7 cited sources.
🔑 Enhanced Key Takeaways
- •Rivia was founded in 2022 by Erik Scalfaro and Tiago Kielige as a cloud-based AI analytics platform for biotech clinical trials.[3]
- •The €3M seed round in June 2024 was led by Speedinvest, with participation from Nina Capital and Amino Collective.[1][3]
- •Rivia's platform includes Rivia Core, an AI Data Integration Engine that standardizes data into SDTM format in 20 days with hourly updates, and Rivia Spark, a natural language visual intelligence and patient profile assistant.[6]
- •Clients include Abcentra Therapeutics and Alentis Therapeutics, who report improved real-time decision-making and safety monitoring.[1][6]
📊 Competitor Analysis▸ Show
| Feature | Rivia | Medable | Veeva |
|---|---|---|---|
| Focus | Agentic AI data engine for trials | eClinical platform | CRM & trial management |
| Key Tech | AI integration to SDTM, NL queries | Digital trials, patient apps | Cloud Vault for data |
| Pricing | Not disclosed | Subscription-based | Enterprise licensing |
| Benchmarks | Deployed in active trials (undisclosed scale) | 100+ trials accelerated | Serves 20K+ life sci orgs |
🛠️ Technical Deep Dive
- •Rivia Core AI Integration Engine: Maps raw variables from vendor sources/files to standardized relational database in SDTM format within 20 days; runs hourly pipelines for real-time data.[6]
- •Rivia Spark Visual Intelligence: Converts natural language queries into dynamic graphs and cohorts for effortless data exploration.[6]
- •Patient Profile Assistant: AI conversational agent for instant insights on patient adverse events, biomarkers, visits, and trends.[6]
🔮 Future ImplicationsAI analysis grounded in cited sources
⏳ Timeline
📎 Sources (7)
Factual claims are grounded in the sources below. Forward-looking analysis is AI-generated interpretation.
- techfundingnews.com — Swiss Startup Rivia Bags E3m to Revolutionise Clinical Trial Lifecycle with AI
- thenextweb.com — Rivia 13m Agentic AI Clinical Trials
- vestbee.com — Rivia Raises 3 M
- eu-startups.com — Zurich Based Rivia Raises E13 Million to Power Complex Clinical Trials with an Agentic Data Engine
- mordorintelligence.com — AI in Clinical Trials Market
- rivia.com
- iqvia.com — Nine for 2026 Part 1
Weekly AI Recap
Read this week's curated digest of top AI events →
👉Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: The Next Web (TNW) ↗